Summit Global Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Summit Global Investments’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33,225	Closed	-$320K	–	556
2023 Q3	$320K	Buy	33,225 +12,785	+63%	+$125K	0.02%	416
2023 Q2	$217K	Buy	20,440 +7,140	+54%	+$76.7K	0.01%	498
2023 Q1	$140K	Hold	13,300	–	–	0.01%	492
2022 Q4	$165K	Buy	13,300 +300	+2%	+$3.4K	0.01%	448
2022 Q3	$135K	Buy	+13,000	New	+$147K	0.01%	452
2022 Q1	–	Sell	-41,742	Closed	-$487K	–	515
2021 Q4	$487K	Sell	41,742 -35,800	-46%	-$439K	0.03%	365
2021 Q3	$1.01M	Buy	77,542 +9,800	+14%	+$127K	0.08%	198
2021 Q2	$872K	Sell	67,742 -3,300	-5%	-$37.8K	0.05%	248
2021 Q1	$794K	Buy	+71,042	New	+$750K	0.05%	231

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Summit Global Investments's IRWD Position: Q4 2023 in Review

Summit Global Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2023, closing a stake of 33,225 shares — an estimated $320K sold.

Summit Global Investments first reported a position in IRWD in Q1 2021 and held it in 9 quarters. The position peaked at $1.01M in Q3 2021. 251 funds tracked by Wall St. Rank hold IRWD as of Q4 2023.

Summit Global Investments reported no remaining Ironwood Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Summit Global Investments sold 33,225 Ironwood Pharmaceuticals shares in Q4 2023, an estimated $320K.
Summit Global Investments first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 9 quarters.
Summit Global Investments's Ironwood Pharmaceuticals position peaked at $1.01M in Q3 2021.
251 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2023.

Based on Summit Global Investments's 13F filing for Q4 2023, filed 6 Feb 2024.